Advanced Medical Solutions Group plc (AIM:AMS)
London · Delayed Price · Currency is GBP · Price in GBX 280.07
-0.43 (-0.15%)
Jul 28, 2026, 9:01 AM GMT
AIM:AMS Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 9.95 | 7.09 | 15.89 | 20.41 | 17.48 |
Depreciation & Amortization | 18.35 | 14.26 | 9.26 | 7.46 | 7.07 |
Other Amortization | 3.05 | 2.05 | 1.53 | 1.38 | 1.78 |
Stock-Based Compensation | 4.14 | 3.09 | 2.92 | 2.44 | 1.98 |
Other Operating Activities | 7.38 | -0.93 | -1.42 | 1.16 | 1.44 |
Change in Accounts Receivable | 5.04 | -10.38 | -2.52 | -0.6 | -1.77 |
Change in Inventory | -13.27 | -0 | -8.06 | -7.09 | 0.94 |
Change in Accounts Payable | -2.05 | 4.32 | -5.25 | 1.71 | 2.11 |
Operating Cash Flow | 32.59 | 19.49 | 12.35 | 26.88 | 31.03 |
Operating Cash Flow Growth | 67.21% | 57.87% | -54.07% | -13.37% | 44.23% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -7.36 | -4.06 | -3.54 | -3.74 | -1.77 |
Sale of Property, Plant & Equipment | 0.05 | 0.03 | 0.04 | 0.05 | 0.05 |
Cash Acquisitions | 0.07 | -54.13 | -5.53 | -2.78 | - |
Sale (Purchase) of Intangibles | -5.24 | -4.69 | -6.31 | -6.23 | -4.7 |
Other Investing Activities | -0.86 | -4.3 | -4.93 | 0.82 | 0.08 |
Investing Cash Flow | -13.33 | -67.15 | -20.27 | -11.88 | -6.33 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 79.45 | - | - | - |
Short-Term Debt Repaid | -0.58 | - | - | - | - |
Long-Term Debt Repaid | -8.89 | -64.8 | -1.95 | -1.63 | -1.28 |
Total Debt Repaid | -9.46 | -64.8 | -1.95 | -1.63 | -1.28 |
Net Debt Issued (Repaid) | -9.46 | 14.66 | -1.95 | -1.63 | -1.28 |
Issuance of Common Stock | 0.33 | 0.01 | 0.18 | 0.66 | 1.09 |
Repurchase of Common Stock | - | - | -6.71 | -0.39 | -0.37 |
Common Dividends Paid | -5.79 | -5.2 | -4.78 | -4.34 | -3.85 |
Other Financing Activities | -4.05 | -3.99 | -0.36 | -0.62 | -0.7 |
Financing Cash Flow | -18.97 | 5.48 | -13.62 | -6.32 | -5.11 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.69 | -0.94 | -0.56 | 0.62 | -0.46 |
Net Cash Flow | 0.98 | -43.12 | -22.1 | 9.3 | 19.14 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 25.23 | 15.43 | 8.8 | 23.14 | 29.26 |
Free Cash Flow Growth | 63.48% | 75.34% | -61.96% | -20.91% | 52.66% |
Free Cash Flow Margin | 11.02% | 8.69% | 6.97% | 18.61% | 26.94% |
Free Cash Flow Per Share | 0.12 | 0.07 | 0.04 | 0.10 | 0.13 |
Levered Free Cash Flow | 11.26 | -16.24 | 1.7 | 14.6 | 22.05 |
Unlevered Free Cash Flow | 14.41 | -14.02 | 1.94 | 15 | 22.47 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 4.05 | 3.99 | 0.36 | 0.62 | 0.7 |
Cash Income Tax Paid | 5.33 | 5.05 | 4.41 | 3.32 | 4.08 |
Change in Working Capital | -10.28 | -6.07 | -15.83 | -5.97 | 1.28 |